Open Access Article
Xiaodan Chu,
Shaowei Zhang,
Zhuo Wang,
Tongyu Li and
Bolin Zhu
*
Tianjin Key Laboratory of Structure and Performance for Functional Molecules, Key Laboratory of Inorganic–Organic Hybrid Functional Material Chemistry, Ministry of Education, College of Chemistry, Tianjin Normal University, Tianjin 300387, People's Republic of China. E-mail: hxxyzbl@gmail.com; Fax: +86 22 23766532; Tel: +86 22 23766515
First published on 14th February 2018
Reactions of 2-benzoylpyridine or 2-benzylpyridine with [Cp*MCl2]2 (M = Ir, Rh) have been carried out in the presence of NaOAc in refluxing methanol, which form the corresponding six-membered cyclometalated products (1–3) except for the reaction of 2-benzylpyridine with [Cp*RhCl2]2. Insertion reactions of two six-membered cyclometalated pyridine iridium complexes (1 and 2) with terminal or internal aromatic alkynes were studied. Terminal alkynes p-XC6H4C
CH (X = H, MeO, and F) with 1 give the corresponding five- and seven-membered doubly cycloiridated complexes 4a–c, internal alkynes p-XC6H4C
CC6H4X-p (X = H, MeO, and Br) form the similar five- and seven-membered doubly cycloiridated complexes (5a,b) and/or di-insertion products (6a,c), whereas the acyl alkyne PhC
CCOPh affords the novel spiro-metalated complex 7. For complex 2, internal alkynes p-XC6H4C
CC6H4X-p (X = H, MeO, and Br) form similar five- and seven-membered doubly cycloiridated complexes (8a–c). However, in the case of PhC
CCOPh, the reaction gives the novel four-membered cyclometalated complex 9. These results suggest that the products formed by alkyne insertion reactions of the six-membered cycloiridated pyridine complexes are very diverse. Plausible pathways for the formation of these novel insertion products were proposed. Molecular structures of seven cyclometalated complexes were determined by X-ray diffraction.
The structure of 3 is shown in Fig. 1 with selected bond lengths and angles, which reveals a classic three-legged piano stool geometry. The six-membered ring in the structure confirms the activation of a C(sp2)–H bond on α position of phenyl ring. The Rh(1)–N(1) bond distance is 2.079(4) Å, which is slightly shorter than those (2.099(3) and 2.1000(15) Å) in five-membered ring analogues Cp*RhCl(L) (HL = 2-phenylpyridine2c and 2-(4-methoxyphenyl)pyridine).3a
CH (X = H, MeO, and F) in methanol at room temperature resulted in the five-membered and seven-membered doubly cyclometalated complexes 4a–c in moderate yields (Scheme 3). Obviously, the products were different with those double-insertion compounds (II in Scheme 1) generated from the similar reactions of five-membered cyclometalated complexes (M = Ir, Rh) with phenylacetylene.10d It was observed that the reactions with arylacetylene containing an electron-donating substituent (p-OMe) is faster than the reaction with that containing an electron-withdrawing substituent (p-F). The 1H NMR spectrum of 4a showed eleven multiplets, integrating to 12H, assigned to protons of three aromatic rings, one singlet at δ = 6.81 ppm corresponding to the only vinyl proton, and one singlet at δ = 1.45 ppm for Cp* group.
The structure of 4c is shown in Fig. 2 with selected bond lengths and angles. The iridium(III) center is coordinated by a η5 Cp*, one nitrogen atom N(1), and two metalated carbon atoms C(13) and C(16), which come from p-FC6H4C
CH. Two fused rings constitute the molecular framework, one is a five-membered ring, and the other is a seven-membered one, they share two adjacent atoms Ir(1) and C(13). For the five-membered ring, all five atoms in the ring are almost in the same plane. The Ir(1)–N(1) bond distance (2.065(12) Å) is slightly shorter than that (2.085(3) Å) in the analogue which is generated from the reaction of 2-(2,3,4,5-tetrafluorophenyl)pyridine cycloiridated complex with diphenylacetylene.10a
CC6H4X-p were applied to the above reaction. When X was electron-donating substituent (MeO), the reaction mainly afforded the corresponding product 5b and trace amounts of 6b, when X was electron-withdrawing substituent (Br), the reaction mainly afforded the corresponding product 6c and trace amounts of 5c.
The molecular structure of 5a was confirmed by X-ray single crystal diffraction study, which exhibited the structure similar to 4c. The crystal structure and crystallographic data for 5a were provided in the ESI.†
By careful analysis of the crystal structures of 4a and 5a, we found that one carbon atom is inserted into Ir–C(phenyl) bond of 1, and the two phenyl groups in 5a are bound to the same carbon atom, which indicates that the migration of one phenyl group of diphenylacetylene occurs during the reaction. Besides, we also noticed that an ortho C–H bond of phenyl group from alkyne is activated by the iridium center. Based on these results described above, we proposed a plausible pathway for the formation of 4 or 5 in Scheme 5. Firstly, the chloride of 1 dissociates to form a 16-electron cation, and the aromatic alkyne η2-coordinates to metal center to give complex A, which undergoes vinylidene rearrangement to give the phenylvinylidene intermediate B. This is followed by 1,1-insertion of the vinylidene ligand into the Ir–C(phenyl) bond to form C. In the last step, intramolecular activation of an ortho C–H bond of phenyl group occurs to build the second metallacycle, which comes with an elimination of HX to afford the final product 4 or 5. Ishii group reported similar reactions of five-membered cycloiridated pyridine complex with diphenylacetylene derivatives in the presence of NaBArF4,10a which afforded a nine-membered iridacycle complex with a Ir–(vinyl CH) agnostic interaction (IV in Scheme 1), and then followed by a further stirring in MeOH to give the doubly cyclometalated analogues of 4 or 5. Besides, recently we reported similar reactions of five-membered cycloiridated phosphine complex with aromatic alkynes in the absence of NaBArF4, which also produced the corresponding five-membered and six-membered doubly cyclometalated products.12 Based on our results and reported examples of reactions of cycloiridated complexes with aromatic alkynes, we may deduce that this type of doubly cyclometalated complexes are another general products which formed through vinylidene rearrangement of alkynes/1,1-insertion except for the normal seven-membered cyclometalated products generated from 1,2-alkyne insertion, sometimes there exists competition between above two pathways.
The structure of 6c is shown in Fig. 3 with selected bond lengths and angles, which confirms that the two molecules of p-BrC6H4C
CC6H4Br-p are involved in building the molecular framework. The Ir(1)–C(8) bond distance (2.049(5) Å) is slightly longer than that (2.030(5) Å) in the parent 2-benzoylpyridine cycloiridated complex;2b and the Ir(1)–N(1) bond distance (2.106(5) Å) is also slightly longer than that (2.083(4) Å); however the N–Ir–C angles are almost same (86.39(19) and 86.75(16)°, respectively). The angle between the pyridine and phenyl planes (originally from 2-benzoylpyridine ligand) in 6c is 47.2°, which compares with 34.9° in the parent 2-benzoylpyridine cycloiridated complex.2b To the best of our knowledge, the similar structure of 6c has never been reported. Unfortunately, no plausible pathway has yet been proposed to account for the formation of 6c.
CCOPh
CCOPh, which prefers to undergo a vinylidene arrangement as a reactive substrate.13 When a mixture of 1 with PhC
CCOPh and NaBArF4 in C2H4Cl2 was stirred at room temperature for 30 min, an orange crystal was obtained after recrystallization. X-ray diffraction study disclosed that the orange crystal was the novel spiro-metalated complex 7 (Scheme 6).
The structure of 7 was shown in Fig. 4. The iridium(III) center is coordinated by a η5 Cp*, one pyridine ligand, one chlorine atom Cl(1), and one metalated oxygen atom O(1), which comes from the bridging carbonyl group. Two spiro five-membered rings constitute the molecular framework, one is a five-membered ring (C(16)–C(17)–C(18)–C(23)–C(30)), and the other is a metalated five-membered one (Ir(1)–N(1)–C(11)–C(16)–O(1)), they share one carbon atom C(16). All five atoms in each ring are perfectly in the same plane, and the dihedral angle between these two planes is 87.5°, which means that they are almost perpendicular. The Ir(1)–N(1) bond distance (2.098(4) Å) is also slightly longer than that (2.074(5) Å) in the 2-phenylpyridine cycloiridated complex.2c
By careful analysis of the crystal structure of 7, we found that the bridging carbonyl group was involved in the reaction. A plausible pathway for the formation of 7 was proposed in Scheme 7. Firstly, the chloride of 1 dissociates to free up a coordinate space for aromatic alkyne, and then generate a η2-alkyne complex D, which undergoes 1,2-alkyne insertion to give the eight-membered metallacycle E. The most noteworthy is the regioselectivity of the alkyne insertion in this system, the benzoyl group is found on the carbon atom adjacent to the metal, while the phenyl group is on the carbon atom adjacent to the phenyl pyridine. This regioselectivity is the same as that found by Ishii for the reaction of this alkyne with the similar five-membered cycloiridated pyridine complex,10a also the same as that reported by Davies in the reaction of ester alkyne PhC
CCO2Et with the five-membered cycloiridated oxazoline complex.10e Subsequently, this is followed by an intramolecular nucleophilic addition of metal organic reagent to the bridging carbonyl group to form the spiro-metalated intermediate F. In the last step, recoordination of chlorine to metal center in F forms the final neutral product 7. Apparently, 1,2-insertion into the Ir–Cphenyl bond was more favored in this case than vinylidene rearrangement of alkyne.
CC6H4X-p (X = H, MeO, or Br) and NaBArF4 in C2H4Cl2 was stirred at room temperature for 0.5–1.5 h, the five-membered and seven-membered doubly cyclometalated complex 8a–c was formed, which showed the similar structure to complex 5a–c (Scheme 8). In this case, there was no other products obtained, which was different from the case of 1, the latter also formed the other product 6a, the two diarylacetylene involved product. For the effect of substituent on the reactivity, it was observed that the reaction with arylacetylene containing an electron-donating substituent (p-OMe) is faster than the reaction with that containing an electron-withdrawing substituent (p-F), which is consistent with the case of 1.
The structure of 8b is shown in Fig. 5. The iridium(III) center is coordinated by a η5 Cp*, one nitrogen atom N(1), and two metalated carbon atoms C(23) and C(26), which come from p-MeOC6H4C
CC6H4OMe-p. Two fused rings constitute the molecular framework, one is a five-membered ring, and the other is a seven-membered one, they share two adjacent atoms Ir(1) and C(23). For the five-membered ring, all five atoms in this ring are almost in the same plane. The Ir(1)–N(1) bond distance (2.103(4) Å) is slightly shorter than that (2.065(12) Å) in 4c, and almost the same as that (2.088(6) Å) in 5a.
CCOPh
CCOPh and NaBArF4 in C2H4Cl2 was stirred at room temperature for 25 min, a yellow crystal was obtained after recrystallization. X-ray diffraction study disclosed that the yellow crystal was the novel four-membered cyclometalated complex 9 (Scheme 9).
The structure of 9 was shown in Fig. 6. For clarity, the anion BArF4− part is omitted. The iridium cationic center is coordinated by a η5 Cp*, a η2 C
C double bond, one nitrogen atom N(1), and one metalated carbon atoms C(16), which comes from the bridging methylene group. The four-membered ring (Ir(1)–N(1)–C(15)–C(16)) adopts a nonplanar “puckered” conformation. The Ir(1)–C(16) bond distance is 2.125(4) Å, which is shorter than those (2.235(4) and 2.193(4) Å) in Ir(1)(η2–(C(23)
C(30))) unit, but longer than that (2.062(12) Å) in five-membered metallacycle analogue 4c, which might be ascribed to the strain of four-membered ring.
By careful analysis of the crystal structure of 9, we found that the bridging methylene group was involved in the reaction. We proposed a plausible pathway for the formation of 9 in Scheme 10. The first two steps are similar to that for the formation of 7, which afford the corresponding η2-alkyne intermediate G and 16e− unsaturated iridium species H. This is followed by oxidative addition of a C–H bond of methylene group to form I. In the final step, reductive elimination of vinyl and hydro groups on the metal to give an alkene, which subsequently coordinates to metal center in η2-mode to give the final product 9. Also, 1,2-insertion into the Ir–Cphenyl bond was more favored in this case than vinylidene rearrangement of alkyne.
By comparing the above two pathways for formation of 7 and 9 (Schemes 8 and 10), we observed something in common between them: both of two eight-membered metallacycle intermediates (E and H) underwent an intramolecular reaction. The former is a nucleophilic addition to the bridging carbonyl group, and the latter is oxidative addition of a C–H bond on methylene group. The driving force for the above two reactions may come from the flexibility of eight-membered rings and the stability of the resulting products. While the similar reaction of five-membered cyclometalated iridium complex [Cp*IrCl(ppy-F4)] (ppy-F4 = 2,3,4,5-tetrafluoro-6-(2-pyridyl)phenyl) with PhC
CCOPh afforded the ten-membered iridacycle complex and the vinyliridium complex by the corresponding 1,2-alkyne insertion and vinylidene rearrangement/1,1-insertion.10a
In summary, insertion reactions of the six-membered cyclometalated pyridine iridium complexes with terminal or internal aromatic alkynes were firstly reported, which showed different reactivity from those of the five-membered cyclometalated iridium analogues. The resulting stable products presented the wide diversity, which were formed from either 1,2-alkyne insertion or vinylidene rearrangement/1,1-alkyne insertion mode and then further intramolecular transformation. These results may also explain why [Cp*IrCl2]2 is catalytically inactive in the catalytic reaction of 2-benzoylpyridine or 2-benzylpyridine with aromatic alkynes.
CH (X = H, MeO, and F), and p-XC6H4C
CC6H4X-p (X = H and Br) were purchased from Sigma-Aldrich and used as received. p-MeOC6H4C
CC6H4MeO-p14 and PhC
CCOPh15 were synthesized according to the literature.
:
1) as the eluent. The products were recrystallized from n-hexane/CH2Cl2 (1
:
1) at −10 °C to afford 1–3 as orange, yellow, or red crystals.
1, reaction time 6 h, orange crystals (85% yield). The NMR data for 1 are consistent with reported data.2b
2, reaction time 2 h, yellow crystals (92% yield). The NMR data for 2 are consistent with reported data.3b
3, reaction time 5 h, red crystals (41% yield). 1H NMR δ 9.27 (d, J = 5.3 Hz, 1H), 8.18 (d, J = 7.5 Hz, 1H), 7.94 (t, J = 7.3 Hz, 1H), 7.87 (dd, J = 11.2, 7.7 Hz, 2H), 7.50 (dd, J = 11.9, 5.7 Hz, 1H), 7.31 (d, J = 6.0 Hz, 1H), 7.09 (dd, J = 13.6, 6.0 Hz, 1H), 1.34 (s, 15H, Cp*). 13C{1H} NMR: δ 191.2, 172.9 (d, J = 30 Hz), 156.1, 155.3, 139.8, 138.2, 137.1, 132.2, 129.4, 127.1, 125.6, 123.6, 96.8 (d, J = 6.3 Hz), 8.7. Anal. calcd for C22H23ClNORh: C, 57.97; H, 5.09. Found: C, 57.74; H, 5.06.
:
1) as the eluent. The products were recrystallized from n-hexane/CH2Cl2 at −10 °C to afford 4a–c as red or deep red crystals.
4a, red crystals (48% yield). 1H NMR (400 MHz, CDCl3) δ 8.50 (d, J = 5.1 Hz, 1H), 7.83 (dd, J = 7.8, 1.1 Hz, 1H), 7.70 (dd, J = 5.8, 2.7 Hz, 1H), 7.54 (d, J = 7.8, 1.5 Hz, 1H), 7.41 (d, J = 7.5, 1.3 Hz, 1H), 7.30 (d, J = 6.8 Hz, 1H), 7.18–7.13 (m, 1H), 7.09 (dd, J = 7.9, 0.9 Hz, 1H), 7.04 (dd, J = 5.9, 2.8 Hz, 1H), 6.89–6.79 (m, 4H), 1.45 (s, 15H, Cp*). 13C{1H} NMR: δ 194.1, 168.4, 161.1, 160.6, 156.3, 156.2, 152.6, 141.9, 136.9, 135.0, 133.2, 131.9, 130.5, 125.8, 125.1, 124.8 (two peaks), 124.5, 122.3, 121.4, 90.1, 8.8. Anal. calcd for C30H28IrNO: C, 59.00; H, 4.62. Found: C, 58.85; H, 4.71.
4b, deep red crystals (52% yield). 1H NMR (400 MHz, CDCl3) δ 8.53 (d, J = 5.6 Hz, 1H), 7.81 (d, J = 7.7 Hz, 1H), 7.54 (t, J = 7.6 Hz, 1H), 7.38 (d, J = 7.4 Hz, 1H), 7.33 (d, J = 2.3 Hz, 1H), 7.28 (d, J = 7.4 Hz, 1H), 7.15–7.07 (m, 2H), 6.98 (d, J = 8.1 Hz, 1H), 6.84 (t, J = 6.8 Hz, 1H), 6.76 (s, 1H), 6.44 (d, J = 5.6 Hz, 1H), 3.89 (s, 3H, CH3), 1.45 (s, 15H, Cp*). 13C{1H} NMR: δ 194.2, 168.4, 163.0, 156.6, 156.4, 154.2, 152.5, 152.3, 141.1, 136.9, 133.2, 131.7, 130.5, 125.9, 124.8, 122.2, 121.5, 105.5, 90.0, 55.4, 8.8. Anal. calcd for C31H30IrNO2: C, 58.11; H, 4.72. Found: C, 58.06; H, 4.57.
4c, deep red crystals (42% yield). 1H NMR (400 MHz, CDCl3) δ 8.45 (d, J = 5.9 Hz, 1H), 7.84–7.81 (m, 1H), 7.57 (td, J = 7.8, 1.5 Hz, 1H), 7.44–7.38 (m, 2H), 7.29 (s, 1H), 7.16 (t, J = 7.5 Hz, 1H), 7.10 (d, J = 6.9 Hz, 1H), 7.00–6.95 (m, 1H), 6.87 (m, 1H), 6.76 (s, 1H), 6.58–6.52 (m, 1H), 1.44 (s, 15H, Cp*). 13C{1H} NMR: δ 194.1, 168.4, 159.1, 156.5, 156.1, 154.3, 152.6, 140.6, 137.1, 133.3, 131.8, 130.5, 125.8, 125.1, 124.9, 121.7, 121.2, 121.1, 108.0, 107.8, 90.1, 8.7. Anal. calcd for C30H27FIrNO: C, 57.31; H, 4.33. Found: C, 57.43; H, 4.46.
5a, reaction time 1 h, 50 °C, orange crystals (27% yield). 1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 5.8 Hz, 1H), 7.90 (dd, J = 7.8, 1.3 Hz, 1H), 7.75 (d, J = 7.2 Hz, 1H), 7.60 (td, J = 7.7, 1.5 Hz, 1H), 7.31 (m, 1H), 7.22 (d, J = 6.8 Hz, 1H), 7.13 (m, 1H), 7.06–6.98 (m, 3H), 6.95–6.89 (m, 3H), 6.79 (m, 2H), 6.58 (m, 2H), 1.46 (s, 15H, Cp*). Anal. calcd for C36H32IrNO: C, 62.95; H, 4.70. Found: C, 63.06; H, 4.73.
6a, reaction time 1 h, 50 °C, orange crystals (65% yield). 1H NMR (400 MHz, CDCl3) δ 9.10 (dd, J = 5.9, 1.4 Hz, 1H), 7.64 (dd, J = 7.6, 1.2 Hz, 1H), 7.59 (d, J = 7.5 Hz, 1H), 7.50–7.44 (m, 1H), 7.38–7.31 (m, 3H), 7.24 (d, J = 7.3 Hz, 2H), 7.16–6.91 (m, 14H), 6.66 (dd, J = 9.2, 7.6 Hz, 3H), 6.40 (dd, J = 7.6, 1.2 Hz, 2H), 1.54 (s, 15H, Cp*). 13C{1H} NMR: δ 161.9, 159.1, 146.0, 143.6, 141.6, 139.5, 138.3, 137.0, 136.5, 136.3, 136.2, 134.8, 132.8, 131.9, 129.7, 128.7 (two peaks), 128.4, 128.3, 128.2, 128.1, 127.5, 127.2 (two peaks), 127.1, 127.0, 124.8, 120.7, 120.5, 89.6, 89.3, 9.6. Anal. calcd for C50H43ClIrNO: C, 66.61; H, 4.81. Found: C, 66.39; H, 4.88.
5b, reaction time 40 min, room temperature, green crystals (72% yield). 1H NMR (400 MHz, CDCl3) δ 8.39 (d, J = 5.0 Hz, 1H), 7.88 (dd, J = 7.8, 1.1 Hz, 1H), 7.59 (td, J = 7.8, 1.4 Hz, 1H), 7.40 (d, J = 2.5 Hz, 1H), 7.21 (d, J = 6.9 Hz, 1H), 7.03 (d, J = 7.5, 1.4 Hz, 1H), 6.92 (t, J = 7.1 Hz, 1H), 6.80 (m, 1H), 6.67 (m, 4H), 6.58 (d, J = 7.6 Hz, 1H), 6.52 (d, J = 8.2 Hz, 1H), 6.37 (dd, J = 8.3, 2.5 Hz, 1H), 3.88 (s, 3H, CH3), 3.72 (s, 3H, CH3), 1.46 (s, 15H, Cp*). 13C{1H} NMR: δ 194.1, 168.6, 162.9, 157.3, 157.2, 154.5, 152.6, 150.1, 148.7, 137.1, 134.0, 132.3, 132.1, 131.7, 130.3, 129.2, 124.4, 124.2, 123.7, 123.1, 122.0, 113.1, 105.0, 90.3, 55.4, 55.2, 8.8. Anal. calcd for C38H36IrNO3: C, 61.11; H, 4.86. Found: C, 60.95; H, 4.92.
6c, reaction time 1.5 h, 50 °C, orange crystals (74% yield). 1H NMR (400 MHz, CDCl3) δ 9.08 (d, J = 5.8 Hz, 1H), 7.64 (m, 1H), 7.55 (d, J = 4.1 Hz, 2H), 7.49 (d, J = 8.4 Hz, 2H), 7.24 (m, 2H), 7.20 (d, J = 8.4 Hz, 2H), 7.17 (m, 1H), 7.14 (m, 1H), 7.03 (d, J = 7.6 Hz, 2H), 6.99 (t, J = 7.6 Hz, 2H), 6.92 (d, J = 8.4 Hz, 2H), 6.53–6.48 (m, 3H), 6.34 (m, 1H), 6.21 (m, 1H), 5.88 (m, 1H), 1.51 (s, 15H, Cp*). Anal. calcd for C50H39Br4ClIrNO: C, 49.34; H, 3.23. Found: C, 49.55; H, 3.12.
7, reaction time 30 min, room temperature, orange crystals (61% yield). 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 5.4 Hz, 1H), 7.70 (s, 3H), 7.52 (dd, J = 11.0, 4.3 Hz, 2H), 7.28 (d, J = 6.9 Hz, 1H), 7.25–7.20 (m, 5H), 7.16–7.07 (m, 5H), 6.78 (d, J = 8.0 Hz, 1H), 1.49 (s, 15H, Cp*). Anal. calcd for C37H33ClIrNO2: C, 59.15; H, 4.43. Found: C, 59.13; H, 4.61.
8a, reaction time 40 min, room temperature, brown crystals (34% yield). 1H NMR (400 MHz, CDCl3) δ 7.68 (t, J = 7.3 Hz, 2H), 7.45–7.42 (m, 1H), 7.15 (m, 3H), 7.11 (dd, J = 8.3, 7.1 Hz, 1H), 6.84 (td, J = 7.4, 1.5 Hz, 2H), 6.80 (m, 4H), 6.76–6.68 (m, 2H), 6.62 (d, J = 7.1 Hz, 1H), 6.41 (dd, J = 7.4, 1.3 Hz, 1H), 4.14 (d, J = 19.2 Hz, 1H), 3.91 (d, J = 19.2 Hz, 1H), 1.67 (d, J = 3.3 Hz, 15H, Cp*). Anal. calcd for C36H34IrN: C, 64.26; H, 5.09. Found: C, 64.11; H, 5.22.
8b, reaction time 25 min, room temperature, brown crystals (33% yield). 1H NMR (400 MHz, CDCl3) δ 8.53 (d, J = 4.4 Hz, 1H), 7.51 (d, J = 2.6 Hz, 1H), 7.38 (m, 1H), 7.27 (m, 5H), 7.14 (d, J = 7.0 Hz, 1H), 6.88 (m, 1H), 6.83 (m, 1H), 6.57 (d, J = 8.3 Hz, 1H), 6.50 (t, J = 6.0 Hz, 1H), 6.43 (d, J = 8.1 Hz, 1H), 6.34 (m, 1H), 4.29 (d, J = 13.9 Hz, 1H), 4.08 (d, J = 14.3 Hz, 1H), 3.89 (s, 3H, CH3), 3.69 (s, 3H, CH3), 1.57 (s, 15H, Cp*). Anal. calcd for C38H38IrNO2: C, 62.27; H, 5.23. Found: C, 62.22; H, 5.39.
8c, reaction time 1.5 h, room temperature, brown crystals (29% yield). 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 1.9 Hz, 1H), 7.67 (d, J = 8.3 Hz, 1H), 7.35 (m, 1H), 7.26 (m, 3H), 7.20–7.17 (m, 3H), 7.15 (t, J = 5.3 Hz, 1H), 6.92 (m, 2H), 6.84 (m, 1H), 6.67 (d, J = 7.2 Hz, 1H), 6.26 (d, J = 7.9 Hz, 1H), 4.13 (d, J = 19.9 Hz, 1H), 3.94 (d, J = 19.3 Hz, 1H), 1.66 (s, 15H, Cp*). 13C{1H} NMR: δ 182.1, 154.1, 150.3, 147.0, 146.9, 138.0, 136.9, 135.1, 132.4, 131.6, 128.3, 127.5, 127.1, 126.2, 123.7, 122.7, 119.8, 117.4, 114.7, 93.9, 91.3, 48.6, 9.0. Anal. calcd for C36H32Br2IrN: C, 52.05; H, 3.88. Found: C, 51.79; H, 4.03.
9, reaction time 25 min, room temperature, brown crystals (28% yield). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 7.5 Hz, 2H), 7.72–7.65 (m, 11H), 7.60 (t, J = 7.4 Hz, 1H), 7.49 (s, 4H), 7.44 (t, J = 8.0 Hz, 3H), 7.30 (d, J = 7.8 Hz, 1H), 7.24–7.16 (m, 4H), 7.10–6.97 (m, 4H), 6.82 (d, J = 8.0 Hz, 1H), 4.27 (s, 1H), 1.16 (s, 15H, Cp*). Anal. calcd for C69H47BF24IrNO: C, 52.95; H, 3.03. Found: C, 52.76; H, 2.92.
:
1). Data collection was performed on an Oxford Diffraction SuperNova diffractometer, processed with CrysalisPro, and processed with Olex2, using ShelXT as the solution program and refined with SheLX-2014/7, or on a Bruker SMART 1000, using graphite-monochromated Mo Kα radiation (ω–2θ scans, λ = 0.71073 Å). The crystal data and summary of X-ray data collection are presented in Tables S1 and S2 in the ESI.†
Footnote |
| † Electronic supplementary information (ESI) available. CCDC 1589484–1589490. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c7ra13547e |
| This journal is © The Royal Society of Chemistry 2018 |